ClinicalTrials.Veeva

Menu

Epigenetics in Lupus Nephritis (Epi_LN)

U

University of Göttingen

Status

Unknown

Conditions

Lupus Nephritis
Systemic Lupus Erythematosus

Treatments

Diagnostic Test: Blood sampling

Study type

Observational

Funder types

Other

Identifiers

NCT04648059
28/9/17

Details and patient eligibility

About

This is a translational study for the identification of epigenetic changes detectable in sera of patients suffering from Systemic Lupus erythematosus. The aim of the study is to analyze whether circulating DNA fragments are 1) different in patients with or without Lupus nephritis and 2) present and detectable in the circulation before the development of Lupus nephritis.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of systemic lupus erythematosus according to the current classification criteria
  • a subgroup requires the presence of Lupus nephritis (no restriction to specific LN histologic subtypes)

Exclusion criteria

  • patients not able or unwilling to provide written informed consent

Trial design

60 participants in 2 patient groups

Lupus nephritis +ve
Description:
This group consists of patients with Lupus nephritis
Treatment:
Diagnostic Test: Blood sampling
Lupus nephritis -ve
Description:
This group consist of patients with SLE without Lupus nephritis
Treatment:
Diagnostic Test: Blood sampling

Trial contacts and locations

1

Loading...

Central trial contact

PETER KORSTEN, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems